iQSTEL Inc Debt Disclosure
NOTE 9 - LOANS PAYABLE
Loans payable at December 31, 2025 and 2024 consisted of the following:
| December 31, | December 31, | Interest | ||||||||||||
| 2025 | 2024 | Term | rate | |||||||||||
| Martus | $ | 97,401 | $ | 103,738 | Note was issued on October 23, 2018 and due on January 2, 2026 | 5.0 | % | |||||||
| Darlene Covid19 | 60,703 | 80,019 | Note was issued on April 1, 2020 and due on March 31, 2026 | 0.0 | % | |||||||||
| Promissory note payable | 217,391 | Note was issued June 11, 2024 and due on June 11, 2025 | 2.0 | % | ||||||||||
| Promissory note payable - acquisition of QXTEL | 1,275,000 | Note was issued April 1, 2024 and due on June 30, 2025 | 4.9 | % | ||||||||||
| Promissory note payable | 271,739 | Note was issued July 16, 2024 and due on July 16, 2025 | 2.0 | % | ||||||||||
| Promissory note payable | 271,739 | Note was issued July 31, 2024 and due on July 31, 2025 | 2.0 | % | ||||||||||
| Promissory note payable | 190,217 | Note was issued September 23, 2024 and due on September 23, 2025 | 2.0 | % | ||||||||||
| Promissory note payable | 108,696 | Note was issued October 4, 2024 and due on September 23, 2025 | 2.0 | % | ||||||||||
| Promissory note payable | 794,737 | Note was issued July 16, 2025 and due on February 26, 2026 | 24.0 | % | ||||||||||
| Promissory note payable | 794,737 | Note was issued August 8, 2025 and due on March 21, 2026 | 24.0 | % | ||||||||||
| Promissory note payable | 794,737 | Note was issued September 11, 2025 and due on April 24, 2026 | 24.0 | % | ||||||||||
| Promissory note payable | 531,579 | Note was issued October 14, 2025 and due on May 27, 2026 | 24.0 | % | ||||||||||
| Promissory note payable | 531,579 | Note was issued November 10, 2025 and due on June 23, 2026 | 24.0 | % | ||||||||||
| Promissory note payable | 531,579 | Note was issued December 22, 2025 and due on August 4, 2026 | 24.0 | % | ||||||||||
| Financing loan | 42,253 | $1,148.94 monthly payment for 48 months through January 2029 | 7.87 | % | ||||||||||
| Total | 4,179,305 | 2,518,539 | ||||||||||||
| Less: Unamortized debt discount | (127,170 | ) | (62,898 | ) | ||||||||||
| Total loans payable | 4,052,135 | 2,455,641 | ||||||||||||
| Less: Current portion of loans payable | (4,020,833 | ) | (2,455,641 | ) | ||||||||||
| Long-term loans payable | $ | 31,302 | $ | |||||||||||
Loans payable - related parties at December 31, 2025 and 2024 consisted of the following:
| December 31, | December 31, | Interest | ||||||||||||
| 2025 | 2024 | Term | rate | |||||||||||
| 49% of Shareholder of SwissLink | $ | $ | % | |||||||||||
| 49% of Shareholder of SwissLink | % | |||||||||||||
| Minority Shareholder of QXTEL | Note was due on | % | ||||||||||||
| Total | 125,409 | 720,485 | ||||||||||||
| Less: Current portion of loans payable - related parties | 125,409 | 720,485 | ||||||||||||
| Long-term loans payable - related parties | $ | $ | ||||||||||||
During the years ended December 31, 2025 and 2024, the Company borrowed from third parties totaling $7,420,322 and $5,041,532, which includes original issue discount and financing costs of $455,322 and $546,680 and repaid the principal amount of $2,305,825, including repayments of payable issued for acquisition of subsidiary of $2,275,000 and $2,571,139, respectively.
During the year ended December 31, 2025, the Company issued a note payable of $1,000,000 for the earn out payment related to the April 1, 2024 acquisition of a subsidiary. During the year ended December 31, 2025, the Company issued a note payable of $100,000 for consideration related to the July 1, 2025 acquisition of a subsidiary. These notes were fully repaid during the year ended December 31, 2025.
During the years ended December 31, 2025 and 2024, the Company recorded interest expense of $556,051 and $293,671 and recognized amortization of discount, included in interest expense, of $179,659 and $300,303, respectively.
During the year ended December 31, 2025, the Company settled loans as follows;
| • | Principal amount and accrued interest of 5 notes payable issued in June through October 2024 by issuing shares of common stock. As a result, the Company recorded a loss on settlement of debt of $801,255. | ||
| • | Principal amount and accrued interest of 3 notes payable issued in June 2025 by issuing shares of Series D Preferred Stock. As a result, the Company recorded a loss on settlement of debt of $804,599. | ||
| • | Principal amount and accrued interest of 4 notes payable issued in January through May 2025 by issuing shares of common stock. As a result, the Company recorded a loss on settlement of debt of $541,290. | ||
During the year ended December 31, 2024, the Company settled 2 loans as follows:
| • | Principal amount and accrued interest of a note payable issued in April 2023 by issuing shares of common stock. As a result, the Company recorded a loss on settlement of debt of $102,660. | ||
| • | Principal amount of future receipts loan issued in April 2024 by early settlement. As a result, the Company recorded a loss on settlement of debt of $27,537. |
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Apr 6, 2026 | Showing above |
| 2024 | Mar 31, 2025 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.